Washington blocks investment in sensitive Chinese technology

The U.S. government has proposed new restrictions on American investments in sensitive technology sectors in China, including AI and biotechnology. These regulations aim to enhance control over investments in adversarial countries to protect national security. The proposals will undergo public consultation before final approval and seek to limit China's access to critical technologies. Concerns have been raised about the implications for the biotech industry, which relies on Chinese partnerships for drug development. The Biotechnology Innovation Organization has expressed worries about the potential negative impact on U.S. competitiveness. However, certain existing trade agreements will be exempt from these new rules.